The market for testing and diagnostic laboratories is undergoing a period of dynamic consolidation. Growth through acquisitions promises economies of scale and new synergies, but at the same time presents laboratory organisations with significant operational and technological challenges.
This white paper is aimed at specialists and executives from laboratory organisations, the diagnostics sector and private equity firms who wish to successfully implement M&A projects within a regulated environment.